Aging-Related Funding Announcements

Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required). This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of the participating IC. Consultation with IC staff is strongly encouraged prior to the submission of the clinical trial implementation application. This FOA is not intended for support of clinical trials that do not require an extended project period of 6 or 7 years. [Posted on 1/15/2023. Expires on 1/14/2026]

NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed). The purpose of the NIA K22 Career Transition Award is to facilitate the transition of mentored, postdoctoral researchers to tenure-track or equivalent faculty positions conducting research that advances the mission of NIA. This award does not provide postdoctoral phase funding; therefore, candidates should be prepared to transition to tenure-track or equivalent faculty positions within 12 months after confirmation of a positive funding decision. After transition to an approved faculty position at an extramural institution/organization, the award will provide three years of protected research time through salary and research support. [Posted on 2/13/2024. Expires on 11/13/2025]

NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed). The purpose of this notice of funding opportunity (NOFO) is to provide support for established investigators who have the expertise and leadership skills to enhance aging and/or Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) research capacity within their academic institution. [Posted on 11/6/2024. Expires on 11/13/2027]

NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required). This Notice of Funding Opportunity (NOFO) invites applications for implementation of investigator-initiated multi-site interventional clinical trials (all phases). The trials should be hypothesis-driven, milestone-defined, and related to NIA’s research mission. Information about NIA’s mission can be found on the NIA website. [Posted on 11/6/2024. Expires on 1/8/2026]

Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed). This Notice of Funding Opportunity (NOFO) encourages research grant applications directed toward developing next-generation human cell-derived microphysiological systems (MPS) and related assays that replicate complex nervous system architectures and physiology with improved fidelity over current capabilities. Supported projects will be expected to enable future studies of complex nervous system development, function and aging in healthy and disease states. [Posted on 11/6/2024. Expires on 1/8/2026]

Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed). This Notice of Funding Opportunity (NOFO) encourages research grant applications directed toward developing next-generation human cell-derived microphysiological systems (MPS) and related assays that replicate complex nervous system architectures and physiology with improved fidelity over current capabilities. Supported projects will be expected to enable future studies of complex nervous system development, function, and aging in healthy and disease states. [Posted on 11/6/2024. Expires on 1/8/2026]

Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional). This NOFO invites applications that propose advanced-stage development and utilization of novel research infrastructure to advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. Applicants are expected to have an existing research infrastructure developed with other NIH or non-NIH support. Through this award, investigators will endeavor to develop a mature and sustainable research infrastructure to support projects that address key interdisciplinary aging research questions. [Posted on 11/2/2024. Expires on 12/3/2025]

Innovative Interdisciplinary Research on Female Reproductive Aging. NIA is issuing this notice to encourage innovative interdisciplinary research on the molecular, cellular, and physiological processes involved in female reproductive aging, with the goal to identify and understand key biological pathways involved in aging associated health outcomes in women across the lifespan. Interdisciplinary research that integrates knowledge, expertise, and perspectives from different disciplines may help to give a more complete understanding of the biological drivers of female reproductive aging, as well as provide novel insights into the complexity of overall aging in females. [Posted 12/11/2024. Expires 5/8/2028] 

The Research Centers Collaborative Network (RCCN) goal is to catalyze enduring, collaborative, interdisciplinary research projects across NIA center programs by funding pilot, planning or meeting grants of up to $65,000. Proposals should address topics spanning …

Clinician-Scientists Transdisciplinary Aging Research Coordinating Center (Clin-STAR) Aging Research Development and Training Awards aim to prepare early career investigators for careers in aging-related research and stimulate new collaborations focused on the development of clinically relevant …